ID   A2MG_RAT                Reviewed;        1472 AA.
AC   P06238; Q4FZY3;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 2.
DT   24-JUL-2024, entry version 178.
DE   RecName: Full=Alpha-2-macroglobulin;
DE            Short=Alpha-2-M;
DE   Flags: Precursor;
GN   Name=A2m; Synonyms=A2m1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   TISSUE=Liver;
RX   PubMed=2432068; DOI=10.1016/s0021-9258(19)75947-x;
RA   Gehring M.R., Shiels B.R., Northemann W., de Bruijn M.H.L., Kan C.-C.,
RA   Chain A.C., Noonan D.J., Fey G.H.;
RT   "Sequence of rat liver alpha 2-macroglobulin and acute phase control of its
RT   messenger RNA.";
RL   J. Biol. Chem. 262:446-454(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-164.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=2466233; DOI=10.1093/nar/17.3.1121;
RA   Kunz D., Zimmermann R., Heisig M., Heinrich P.C.;
RT   "Identification of the promoter sequences involved in the interleukin-6
RT   dependent expression of the rat alpha 2-macroglobulin gene.";
RL   Nucleic Acids Res. 17:1121-1138(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 178-227 AND 420-526.
RX   PubMed=2414291; DOI=10.1016/s0021-9258(17)38706-9;
RA   Hayashida K., Okubo H., Noguchi M., Yoshida H., Kangawa K., Matsuo H.,
RA   Sakaki Y.;
RT   "Molecular cloning of DNA complementary to rat alpha 2-macroglobulin
RT   mRNA.";
RL   J. Biol. Chem. 260:14224-14229(1985).
RN   [5]
RP   TISSUE SPECIFICITY.
RC   STRAIN=Fischer 344; TISSUE=Liver;
RX   PubMed=1725450;
RA   Eggertsen G., Hudson G., Shiels B., Reed D., Fey G.H.;
RT   "Sequence of rat alpha 1-macroglobulin, a broad-range proteinase inhibitor
RT   from the alpha-macroglobulin-complement family.";
RL   Mol. Biol. Med. 8:287-302(1991).
CC   -!- FUNCTION: Is able to inhibit all four classes of proteinases by a
CC       unique 'trapping' mechanism. This protein has a peptide stretch, called
CC       the 'bait region' which contains specific cleavage sites for different
CC       proteinases. When a proteinase cleaves the bait region, a
CC       conformational change is induced in the protein which traps the
CC       proteinase. The entrapped enzyme remains active against low molecular
CC       weight substrates (activity against high molecular weight substrates is
CC       greatly reduced). Following cleavage in the bait region a thioester
CC       bond is hydrolyzed and mediates the covalent binding of the protein to
CC       the proteinase.
CC   -!- SUBUNIT: Homotetramer; disulfide-linked.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Highest constitutive expression in ovary. Low level
CC       in testis, uterus and non-acute phase liver. Protein found in plasma.
CC       {ECO:0000269|PubMed:1725450}.
CC   -!- INDUCTION: By inflammatory stimulus in liver. The level of this protein
CC       increases during acute phase, then decreases again.
CC       {ECO:0000269|PubMed:2432068}.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I39 (alpha-2-
CC       macroglobulin) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02635; AAA40636.1; -; mRNA.
DR   EMBL; BC098922; AAH98922.1; -; mRNA.
DR   EMBL; X13983; CAA32164.1; -; Genomic_DNA.
DR   EMBL; X13984; CAA32164.1; JOINED; Genomic_DNA.
DR   EMBL; X13985; CAA32164.1; JOINED; Genomic_DNA.
DR   EMBL; M11792; AAA40637.1; -; mRNA.
DR   EMBL; M11793; AAA40638.1; -; mRNA.
DR   PIR; A26122; A26122.
DR   RefSeq; NP_036620.2; NM_012488.2.
DR   RefSeq; XP_003749876.1; XM_003749828.2.
DR   AlphaFoldDB; P06238; -.
DR   SMR; P06238; -.
DR   BioGRID; 246347; 1.
DR   IntAct; P06238; 1.
DR   MINT; P06238; -.
DR   STRING; 10116.ENSRNOP00000019346; -.
DR   MEROPS; I39.004; -.
DR   GlyCosmos; P06238; 11 sites, No reported glycans.
DR   GlyGen; P06238; 11 sites.
DR   PhosphoSitePlus; P06238; -.
DR   jPOST; P06238; -.
DR   PaxDb; 10116-ENSRNOP00000019346; -.
DR   Ensembl; ENSRNOT00000019346.7; ENSRNOP00000019346.5; ENSRNOG00000028896.5.
DR   GeneID; 24153; -.
DR   KEGG; rno:24153; -.
DR   UCSC; RGD:2004; rat.
DR   AGR; RGD:2004; -.
DR   CTD; 2; -.
DR   RGD; 2004; A2m.
DR   eggNOG; KOG1366; Eukaryota.
DR   GeneTree; ENSGT00940000154904; -.
DR   HOGENOM; CLU_001634_0_1_1; -.
DR   InParanoid; P06238; -.
DR   OMA; HVNRTEV; -.
DR   OrthoDB; 2970602at2759; -.
DR   PhylomeDB; P06238; -.
DR   TreeFam; TF313285; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-8963896; HDL assembly.
DR   PRO; PR:P06238; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000028896; Expressed in ovary and 14 other cell types or tissues.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0048403; F:brain-derived neurotrophic factor binding; IDA:RGD.
DR   GO; GO:0048306; F:calcium-dependent protein binding; ISO:RGD.
DR   GO; GO:0004866; F:endopeptidase inhibitor activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0019838; F:growth factor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0019966; F:interleukin-1 binding; ISO:RGD.
DR   GO; GO:0019959; F:interleukin-8 binding; ISO:RGD.
DR   GO; GO:0048406; F:nerve growth factor binding; IDA:RGD.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0043120; F:tumor necrosis factor binding; ISO:RGD.
DR   GO; GO:0002438; P:acute inflammatory response to antigenic stimulus; IEP:RGD.
DR   GO; GO:0006953; P:acute-phase response; IEP:RGD.
DR   GO; GO:1990402; P:embryonic liver development; IEP:RGD.
DR   GO; GO:0001553; P:luteinization; IEP:RGD.
DR   GO; GO:0001869; P:negative regulation of complement activation, lectin pathway; ISO:RGD.
DR   GO; GO:0010037; P:response to carbon dioxide; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0034695; P:response to prostaglandin E; IEP:RGD.
DR   GO; GO:0048863; P:stem cell differentiation; ISO:RGD.
DR   CDD; cd02897; A2M_2; 1.
DR   Gene3D; 1.50.10.20; -; 1.
DR   Gene3D; 2.20.130.20; -; 1.
DR   Gene3D; 2.60.120.1540; -; 1.
DR   Gene3D; 2.60.40.1930; -; 2.
DR   Gene3D; 2.60.40.1940; -; 1.
DR   Gene3D; 2.60.40.690; Alpha-macroglobulin, receptor-binding domain; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR009048; A-macroglobulin_rcpt-bd.
DR   InterPro; IPR036595; A-macroglobulin_rcpt-bd_sf.
DR   InterPro; IPR050473; A2M/Complement_sys.
DR   InterPro; IPR011625; A2M_N_BRD.
DR   InterPro; IPR041813; A2M_TED.
DR   InterPro; IPR047565; Alpha-macroglob_thiol-ester_cl.
DR   InterPro; IPR011626; Alpha-macroglobulin_TED.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR001599; Macroglobln_a2.
DR   InterPro; IPR019742; MacrogloblnA2_CS.
DR   InterPro; IPR002890; MG2.
DR   InterPro; IPR041555; MG3.
DR   InterPro; IPR040839; MG4.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   PANTHER; PTHR11412:SF165; ALPHA-2-MACROGLOBULIN; 1.
DR   PANTHER; PTHR11412; MACROGLOBULIN / COMPLEMENT; 1.
DR   Pfam; PF00207; A2M; 1.
DR   Pfam; PF07703; A2M_BRD; 1.
DR   Pfam; PF07677; A2M_recep; 1.
DR   Pfam; PF01835; MG2; 1.
DR   Pfam; PF17791; MG3; 1.
DR   Pfam; PF17789; MG4; 1.
DR   Pfam; PF07678; TED_complement; 1.
DR   SMART; SM01360; A2M; 1.
DR   SMART; SM01359; A2M_N_2; 1.
DR   SMART; SM01361; A2M_recep; 1.
DR   SMART; SM01419; Thiol-ester_cl; 1.
DR   SUPFAM; SSF49410; Alpha-macroglobulin receptor domain; 1.
DR   SUPFAM; SSF81296; E set domains; 1.
DR   SUPFAM; SSF48239; Terpenoid cyclases/Protein prenyltransferases; 1.
DR   PROSITE; PS00477; ALPHA_2_MACROGLOBULIN; 1.
PE   2: Evidence at transcript level;
KW   Acute phase; Bait region; Disulfide bond; Glycoprotein; Protease inhibitor;
KW   Reference proteome; Secreted; Serine protease inhibitor; Signal;
KW   Thioester bond.
FT   SIGNAL          1..27
FT   CHAIN           28..1472
FT                   /note="Alpha-2-macroglobulin"
FT                   /id="PRO_0000000058"
FT   REGION          620..750
FT                   /note="Bait region"
FT   CARBOHYD        59
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        74
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        250
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        399
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        651
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        772
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        867
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        989
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1364
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1422
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1426
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        52..90
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        254..302
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        272..290
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        281
FT                   /note="Interchain (with C-434)"
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        434
FT                   /note="Interchain (with C-281)"
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        473..566
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        598..769
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        647..694
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        819..847
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        845..881
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        919..1319
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        1077..1125
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   DISULFID        1350..1465
FT                   /evidence="ECO:0000250|UniProtKB:P01023"
FT   CROSSLNK        970..973
FT                   /note="Isoglutamyl cysteine thioester (Cys-Gln)"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        23
FT                   /note="L -> V (in Ref. 3; CAA32164)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        72
FT                   /note="R -> H (in Ref. 1; AAA40636 and 3; CAA32164)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        103
FT                   /note="V -> L (in Ref. 1; AAA40636 and 3; CAA32164)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        120
FT                   /note="R -> Q (in Ref. 1; AAA40636 and 3; CAA32164)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        490
FT                   /note="M -> L (in Ref. 4; AAA40638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1025
FT                   /note="T -> A (in Ref. 1; AAA40636)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1192
FT                   /note="A -> G (in Ref. 1; AAA40636)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1200
FT                   /note="P -> T (in Ref. 1; AAA40636)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1279
FT                   /note="H -> R (in Ref. 1; AAA40636)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1340
FT                   /note="T -> A (in Ref. 1; AAA40636)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1472 AA;  163785 MW;  BFD63B8A4F6A2632 CRC64;
     MGKHRLRSLA LLPLLLRLLL LLLPTDASAP QKPIYMVMVP SLLHAGTPEK ACFLFSHLNE
     TVAVRVSLES VRGNQSLFTD LVVDKDLFHC TSFTVPQSSS DEVMFFTVQV KGATHEFRRR
     STVLVKKKES LVFAQTDKPI YKPGQTVRFR VVSLDESFHP LNELIPLLYI QDPKNNRIAQ
     WQNFNLEGGL KQLSFPLSSE PTQGSYKVVI RTESGRTVEH PFSVEEFVLP KFEVRVTVPE
     TITILEEEMN VSVCGIYTYG KPVPGRVTVN ICRKYSNPSN CFGEESVAFC EKLSQQLDGR
     GCFSQLVKTK SFQLKRQEYE MQLDVHAKIQ EEGTGVEETG KGLTKITRTI TKLSFVNVDS
     HFRQGIPFVG QVLLVDGRGT PIPYETIFIG ADEANLYINT TTDKHGLARF SINTDDIMGT
     SLTVRAKYKD SNACYGFRWL TEENVEAWHT AYAVFSPSRS FLHLESLPDK LRCDQTLEVQ
     AHYILNGEAM QELKELVFYY LMMAKGGIVR AGTHVLPLKQ GQMRGHFSIL ISMETDLAPV
     ARLVLYAILP NGEVVGDTAK YEIENCLANK VDLVFRPNSG LPATRALLSV MASPQSLCGL
     RAVDQSVLLM KPETELSASL IYDLLPVKDL TGFPQGADQR EEDTNGCVKQ NDTYINGILY
     SPVQNTNEED MYGFLKDMGL KVFTNSNIRK PKVCERLRDN KGIPAAYHLV SQSHMDAFLE
     SSESPTETRR SYFPETWIWD LVVVDSAGVA EVEVTVPDTI TEWKAGAFCL SNDTGLGLSP
     VVQFQAFQPF FVELTMPYSV IRGEAFTLKA TVLNYLPTCI RVAVQLEASP DFLAAPEEKE
     QRSHCICMNQ RHTASWAVIP KSLGNVNFTV SAEALNSKEL CGNEVPVVPE QGKKDTIIKS
     LLVEPEGLEN EVTFNSLLCP MGAEVSELIA LKLPSDVVEE SARASVTVLG DILGSAMQNT
     QDLLKMPYGC GEQNMVLFAP NIYVLDYLNE TQQLTQEIKT KAIAYLNTGY QRQLNYKHRD
     GSYSTFGDKP GRNHANTWLT AFVLKSFAQA RKYIFIDEVH ITQALLWLSQ QQKDNGCFRS
     SGSLLNNAMK GGVEDEVTLS AYITIALLEM SLPVTHPVVR NALFCLDTAW KSARGGAGGS
     HVYTKALLAY AFALAGNQDT KKEILKSLDE EAVKEEDSVH WTRPQKPSVS VALWYQPQAP
     SAEVEMTAYV LLAYLTTEPA PTQEDLTAAM LIVKWLTKQQ NSHGGFSSTQ DTVVALHALS
     KYGSATFTRA KKAAQVTIHS SGTFSTKFQV NNNNQLLLQR VTLPTVPGDY TVKVTGEGCV
     YLQTSLKYSV LPREEEFPFT VVVQTLPGTC EDPKAHTSFQ ISLNISYTGS RSESNMAIAD
     VKMVSGFIPL KPTVKMLERS VHVSRTEVSN NHVLIYLDKV SNQTVNLSFT VQQDIPIRDL
     KPAVVKVYDY YEKDEFAVAK YSAPCSTDYG NA
//
